INCREASED PROTEOLYTIC ACTIVITY IS RESPONSIBLE FOR THE ABERRANT MORPHOGENETIC BEHAVIOR OF ENDOTHELIAL-CELLS EXPRESSING THE MIDDLE T-ONCOGENE

被引:410
作者
MONTESANO, R
PEPPER, MS
MOHLESTEINLEIN, U
RISAU, W
WAGNER, EF
ORCI, L
机构
[1] INST MOLEC PATHOL, A-1030 VIENNA, AUSTRIA
[2] MAX PLANCK INST PSYCHIAT, NEUROCHEM ABT, W-8033 MARTINSRIED, GERMANY
关键词
D O I
10.1016/0092-8674(90)90009-4
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Expression of the polyoma virus middle T (mT) oncogene in vivo is associated with a profound subversion of normal vascular development, which results in the formation of endothelial tumors (hemangiomas). In an attempt to understand the molecular mechanisms responsible for this phenomenon, we have investigated, in an in vitro system, the morphogenetic properties of endothelial cells expressing this oncogene. mT-expressing endothelioma (End) cells grown within fibrin gels formed large hemangioma-like cystic structures. All End cell lines examined expressed high levels of fibrinolytic activity resulting from increased production of urokinase-type plasminogen activator and decreased production of plasminogen activator inhibitors. Neutralization of excess proteolytic activity by exogenously added serine protease inhibitors corrected the aberrant in vitro behavior of End cells and allowed the formation of capillary-like tubules. These results suggest that tightly controlled proteolytic activity is essential for vascular morphogenesis and that physiological protease inhibitors play an important regulatory role in angiogenesis. © 1990.
引用
收藏
页码:435 / 445
页数:11
相关论文
共 44 条
[1]   PLASMINOGEN-ACTIVATOR INHIBITORS - HORMONALLY REGULATED SERPINS [J].
ANDREASEN, PA ;
GEORG, B ;
LUND, LR ;
RICCIO, A ;
STACEY, SN .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1990, 68 (01) :1-19
[2]  
BARRETT AJ, 1986, RES MONOG CELL TISSU, V12, P515
[3]   ENDOTHELIAL-CELL TUMORS DEVELOP IN TRANSGENIC MICE CARRYING POLYOMA-VIRUS MIDDLE T-ONCOGENE [J].
BAUTCH, VL ;
TODA, S ;
HASSELL, JA ;
HANAHAN, D .
CELL, 1987, 51 (04) :529-538
[4]   UROKINASE-TYPE PLASMINOGEN-ACTIVATOR - PROENZYME, RECEPTOR, AND INHIBITORS [J].
BLASI, F ;
VASSALLI, JD ;
DANO, K .
JOURNAL OF CELL BIOLOGY, 1987, 104 (04) :801-804
[5]   ANGIOGENESIS INVITRO [J].
FOLKMAN, J ;
HAUDENSCHILD, C .
NATURE, 1980, 288 (5791) :551-556
[6]   ANGIOGENIC FACTORS [J].
FOLKMAN, J ;
KLAGSBRUN, M .
SCIENCE, 1987, 235 (4787) :442-447
[7]   CULTURED ENDOTHELIAL-CELL MONOLAYERS THAT RESTRICT THE TRANSENDOTHELIAL PASSAGE OF MACROMOLECULES AND ELECTRICAL-CURRENT [J].
FURIE, MB ;
CRAMER, EB ;
NAPRSTEK, BL ;
SILVERSTEIN, SC .
JOURNAL OF CELL BIOLOGY, 1984, 98 (03) :1033-1041
[8]   2 DIFFERENT LAMININ DOMAINS MEDIATE THE DIFFERENTIATION OF HUMAN-ENDOTHELIAL CELLS INTO CAPILLARY-LIKE STRUCTURES INVITRO [J].
GRANT, DS ;
TASHIRO, KI ;
SEGULREAL, B ;
YAMADA, Y ;
MARTIN, GR ;
KLEINMAN, HK .
CELL, 1989, 58 (05) :933-943
[9]   PLASMINOGEN-ACTIVATOR AND COLLAGENASE PRODUCTION BY CULTURED CAPILLARY ENDOTHELIAL-CELLS [J].
GROSS, JL ;
MOSCATELLI, D ;
JAFFE, EA ;
RIFKIN, DB .
JOURNAL OF CELL BIOLOGY, 1982, 95 (03) :974-981
[10]   MECHANOCHEMICAL SWITCHING BETWEEN GROWTH AND DIFFERENTIATION DURING FIBROBLAST GROWTH FACTOR-STIMULATED ANGIOGENESIS INVITRO - ROLE OF EXTRACELLULAR-MATRIX [J].
INGBER, DE ;
FOLKMAN, J .
JOURNAL OF CELL BIOLOGY, 1989, 109 (01) :317-330